🔎 Trials Near Me

Pradžia › Aukštas kraujospūdis › Utah

Aukštas kraujospūdis klinikiniai tyrimai Utah

8 tyrimai dėl Aukštas kraujospūdis ieško dalyvių vietose Utah.

Miestai Utah

Oficialus tyrimo tekstas (anglų kalba)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Ogden Clinic - Canyon View, Ogden
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Olympus Family Medicine, Salt Lake City
  • Velocity Clinical Research-West Jordan-69043, West Jordan
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07064473

: Vascular Function in Health and Disease

  • University of Utah, Salt Lake City
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT02966665

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  • St Marks Hospital, Salt Lake City
Renkami dalyviai
Amžius nuo 22 iki 75 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06559891

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Bountiful
  • Clinical Trial Site, Bountiful
  • Clinical Trial Site, Layton
  • ir dar 1
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT07181109

Global Paradise System US Post Approval Study

  • St. Mark's Hospital, Salt Lake City
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-12 · NCT06297291

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

  • Vanda Investigative Site, Salt Lake City
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-02-27 · NCT07090161

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.